Derivative exercise or conversion — not an open-market buy.
Traded Jan 13, 2026 · Filed Jan 16, 2026
A board member of RH sold $440K of RH shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$440,200
Shares × reported transaction price
33 days after results of Dec 11, 2025, 77 days before results of Mar 31, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −1.9% | −0.3% | −1.6% |
| 30 days | −10.4% | −1.3% | −9.1% |
| 90 days | −44.4% | +1.4% | −45.9% |
| 180 days | −18.3% | +9.1% | −27.4% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
A board member of RH sold $496K of RH shares. Nobody planned it ahead of time.